Advertisement
Home Tags Immunotherapy

Tag: Immunotherapy

For patients with allergic rhinitis

Grass Pollen SLIT Slows Course of Allergic Rhinitis, Asthma

Tx associated with slower AR progression, less frequent asthma onset, slower asthma progression
Administration of allergen immunotherapy in patients with allergic asthma leads to lower short-term symptom and medication scores

Short-Term Benefits for Immunotherapy in Allergic Asthma

Reductions seen in short-term symptom scores and medication scores, with evidence of publication bias
For patients with food allergy

Quality of Life May Drop for Some During Oral Immunotherapy

Patients with better QOL at baseline, might deteriorate after therapy
An experimental immune-system therapy appears safe for patients with progressive forms of multiple sclerosis

AAN: Early Research Promising for Immunotherapy in MS

Investigators employ the relationship between MS and Epstein-Barr virus
Women with advanced

AACR: Atezolizumab Aids Some With Triple-Negative Breast CA

A minority of women with triple-negative tumors responded to atezolizumab, but they responded well
For patients with metastatic renal cell carcinoma receiving immune checkpoint inhibitors

ASCO: Antibiotics May Have Negative Impact in Renal Cancer

Progression-free survival down with antibiotic use for patients receiving immune checkpoint inhibitors
Sublingual grass pollen immunotherapy is not associated with improved nasal response to allergen challenge versus placebo at three-year follow-up in adults with moderate-to-severe seasonal allergic rhinitis

Sublingual Grass Pollen Immunotherapy Has Little Effect

No significant difference from placebo in patients with moderate-to-severe seasonal allergic rhinitis
A new type of immunotherapy involving natural killer cells may help treat acute myeloid leukemia patients

Immunotherapy Promising for Tx of Acute Myeloid Leukemia

In preliminary trial, four of nine patients with acute myeloid leukemia had complete remission
More Americans are benefiting from immunotherapy

AACR: More Cancer Patients Benefiting From Immunotherapy

Therapies help arm the body to fight off malignancy, according to Cancer Progress Report
Immunotherapy with CD19 chimeric antigen receptor-modified T cells in a defined CD4+/CD8+ ratio can lead to improved disease response and overall and progression-free survival

Remission Up With T Cell Therapy for Non-Hodgkin’s Lymphoma

Researchers identify treatment characteristics that correlate with therapeutic response, toxicity